Title : Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia.

Pub. Date : 2021

PMID : 34660293






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Several FLT3 tyrosine kinase inhibitors have been developed in the last few years, but midostaurin is currently the only one approved for the treatment of newly diagnosed patients harboring FLT3 mutations. midostaurin fms related receptor tyrosine kinase 3 Homo sapiens